Aging Female Population Steering Hysteroscope Market Growth
A number of factors, such as the surging prevalence of uterine cancer, soaring female geriatric population, increasing prevalence of infertility due to sedentary lifestyle, rising burden of abnormal uterine bleeding, and burgeoning demand for minimally and non-invasive surgical treatments, are expected to fuel the hysteroscope market at a CAGR of 4.5% during the forecast period (2016–2022).
Read the full report - Hysteroscope Market Insight Report
One of the primary growth drivers for the market is the booming female geriatric population because aged women are vulnerable to several gynecology related disorders, such as abnormal bleeding from the uterus and the formation of fibroids and polyps. According to the World Bank, females aged 50–54 years accounted for 5.76% of the global population in 2020. As aging causes hormonal imbalance among this populace, they often suffer from irregular menstrual cycles, which, in turn, driving the demand for hysteroscope.
The type segment of the hysteroscope market is classified into flexible video (fibre) hysteroscope, flexible non-video (fibre) hysteroscope, and rigid non-video hysteroscope. Under this segment, the rigid non-video hysteroscope category held the largest market share in 2015, and it is expected to maintain its position during the forecast period as well. This device is used to examine the uterine cavity to accurately identify the causes of infertility among women. Also, it helps in detecting the presence of polyps, carcinoma, myomas, intrauterine lesion, malformations, and adhesion in the uterine tract and cavity.
Furthermore, the application segment of the hysteroscope market is categorized into hysteroscopic endometrial ablation, hysteroscopic polypectomy, hysteroscopic myomectomy, and others. Under this segment, the hysteroscopic myomectomy category generated the highest revenue in 2015, and it is also expected to continue this trend throughout the forecast period. Myomectomy is a surgical procedure that is used to take out uterine fibroids or leiomyomas from the body of women who develop fibroids, especially during childbearing years.
Geographically, North America accounted for the largest share in the hysteroscope market in 2015. This is attributed to the rising prevalence of irregular bleeding, uterine related disorders including unexplained miscarriages, and structural abnormalities of the uterus, submucosal myomas, and polyps, in the region. Moreover, the rising population of aged females and their increased susceptibility to uterine infections will also fuel the demand for hysteroscopes in North America.
Therefore, the aging female population and the surging shift from conventional surgeries to minimally invasive surgical procedures are expected to boost the market growth across the world.